{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T16:25:41Z","timestamp":1781886341793,"version":"3.54.5"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 81872014"],"award-info":[{"award-number":["No. 81872014"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","award":["2024ZYD0033"],"award-info":[{"award-number":["2024ZYD0033"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","award":["No. CSTB2023NSCQ-MSX0550"],"award-info":[{"award-number":["No. CSTB2023NSCQ-MSX0550"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CQMU Program for Youth Innovation in Future Medicine","award":["W0089"],"award-info":[{"award-number":["W0089"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Colorectal cancer (CRC) is a serious threat to human health, with an approximate 14% mutation rate in the ataxia telangiectasia-mutated (ATM) gene, which is involved in homologous recombination repair. BMN673 (talazoparib), a next-generation poly(ADP-ribose) polymerase (PARP) inhibitor, is the most potent PARP inhibitor (PARPi) reported to date, demonstrating robust anticancer activity. However, the precise mechanism underlying its action in ATM-deficient CRC remains unknown. This study demonstrated that BMN673 stimulated ATM-deficient CRC cell death via a synthetic lethal effect. RNA sequencing analysis\u00a0revealed significant enrichment of the PERK-ATF4 pathway, mitophagy, and ferroptosis. Functional assays\u00a0confirmed that BMN673 induced a multifaceted cell death program comprising autophagy-associated death, ferroptosis, and mitophagy, in addition to synthetic lethal. Mechanistically, BMN673 was shown to enhance activating transcription factor 4 (ATF4) transcriptional activity by suppressing poly-ADP-ribosylation (PARylation), facilitating ATF4 binding to the growth differentiation factor 15 (GDF15) promoter region and thereby inducing GDF15 transcriptional expression. Notably, GDF15 overexpression modulated the sensitivity of ATM-deficient CRC cells to BMN673 by promoting autophagy-associated cell death, ferroptosis, and mitophagy, contributing to the anticancer effect of BMN673. Additionally, combining BMN673 with radiotherapy exerted a synergistic anticancer effect on ATM-deficient CRC cells, which was prevented by autophagy inhibition. The findings identified the ATF4-GDF15 pathway as a crucial mediator of BMN673 sensitivity in ATM-deficient CRC cells, revealing therapeutic vulnerability beyond canonical DNA damage repair pathways and providing new insight for combination therapy strategies.<\/jats:p>","DOI":"10.1186\/s43556-025-00356-6","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T02:59:03Z","timestamp":1763693943000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["PARP inhibitor BMN673 triggers PARylation-mediated ATF4-GDF15 pathway to drive autophagy and ferroptosis in ataxia telangiectasia mutated gene-deficient colorectal cancer cells"],"prefix":"10.1186","volume":"6","author":[{"given":"Junqi","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiting","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyan","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chundong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Degang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"issue":"2","key":"356_CR1","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3322\/caac.21220","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, Desantis C, Jemal A. Colorectal cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):104\u201317. https:\/\/doi.org\/10.3322\/caac.21220.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"356_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","volume":"71","author":"RL Siegel","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71(1):7\u201333. https:\/\/doi.org\/10.3322\/caac.21654.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"356_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1159\/000543921","volume":"106","author":"T Matsuda","year":"2025","unstructured":"Matsuda T, Fujimoto A, Igarashi Y. Colorectal cancer: epidemiology, risk factors, and public health strategies. Digestion. 2025;106(2):91\u20139. https:\/\/doi.org\/10.1159\/000543921.","journal-title":"Digestion"},{"issue":"1","key":"356_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349. https:\/\/doi.org\/10.3322\/caac.21820.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"356_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21147\/j.issn.1000-9604.2017.01.01","volume":"29","author":"W Chen","year":"2017","unstructured":"Chen W, Zheng R, Zhang S, Zeng H, Zuo T, Xia C, et al. Cancer incidence and mortality in China in 2013: an analysis based on urbanization level. Chin J Cancer Res. 2017;29(1):1\u201310. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2017.01.01.","journal-title":"Chin J Cancer Res"},{"issue":"2","key":"356_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115\u201332. https:\/\/doi.org\/10.3322\/caac.21338.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"356_CR7","doi-asserted-by":"publisher","first-page":"768","DOI":"10.3760\/cma.j.issn.0254-6450.2016.06.005","volume":"37","author":"YJ Feng","year":"2016","unstructured":"Feng YJ, Wang N, Fang LW, Cong S, Yin P, Li YC, et al. Burden of disease of colorectal cancer in the Chinese population, in 1990 and 2013. Zhonghua Liu Xing Bing Xue Za Zhi. 2016;37(6):768\u201372. https:\/\/doi.org\/10.3760\/cma.j.issn.0254-6450.2016.06.005.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"7","key":"356_CR8","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s40265-022-01703-5","volume":"82","author":"R Flippot","year":"2022","unstructured":"Flippot R, Patrikidou A, Aldea M, Colomba E, Lavaud P, Albig\u00e8s L, et al. PARP inhibition, a new therapeutic avenue in patients with prostate cancer. Drugs. 2022;82(7):719\u201333. https:\/\/doi.org\/10.1007\/s40265-022-01703-5.","journal-title":"Drugs"},{"issue":"1","key":"356_CR9","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1002\/mog2.70","volume":"3","author":"M Ge","year":"2024","unstructured":"Ge M, Luo J, Wu Y, Shen G, Kuang XJMO. The biological essence of synthetic lethality: bringing new opportunities for cancer therapy. MedComm \u2013 Oncology. 2024;3(1):e70.","journal-title":"MedComm \u2013 Oncology"},{"issue":"9","key":"356_CR10","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1093\/annonc\/mdz192","volume":"30","author":"J Mateo","year":"2019","unstructured":"Mateo J, Lord CJ, Serra V, Tutt A, Balma\u00f1a J, Castroviejo-Bermejo M, et al. A decade of clinical development of PARP inhibitors in perspective. Ann Oncol. 2019;30(9):1437\u201347. https:\/\/doi.org\/10.1093\/annonc\/mdz192.","journal-title":"Ann Oncol"},{"issue":"1","key":"356_CR11","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00280-025-04810-8","volume":"95","author":"SL Pasupulati","year":"2025","unstructured":"Pasupulati SL, Srinivasa Rao K, Sharma S, Madhavrao C, Rangari G, Misra AK, et al. Clinical pharmacology and therapeutic applications of talazoparib: a comprehensive review. Cancer Chemother Pharmacol. 2025;95(1):87. https:\/\/doi.org\/10.1007\/s00280-025-04810-8.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"2","key":"356_CR12","doi-asserted-by":"publisher","first-page":"e000480","DOI":"10.1136\/esmoopen-2018-000480","volume":"4","author":"B Pellegrino","year":"2019","unstructured":"Pellegrino B, Mateo J, Serra V, Balma\u00f1a J. Controversies in oncology: are genomic tests quantifying homologous recombination repair deficiency (HRD) useful for treatment decision making? ESMO Open. 2019;4(2):e000480. https:\/\/doi.org\/10.1136\/esmoopen-2018-000480.","journal-title":"ESMO Open"},{"issue":"3","key":"356_CR13","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1158\/0008-5472.Can-13-2966","volume":"74","author":"DA Gewirtz","year":"2014","unstructured":"Gewirtz DA. The four faces of autophagy: implications for cancer therapy. Cancer Res. 2014;74(3):647\u201351. https:\/\/doi.org\/10.1158\/0008-5472.Can-13-2966.","journal-title":"Cancer Res"},{"issue":"1","key":"356_CR14","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3892\/ijo.2015.3003","volume":"47","author":"B Arun","year":"2015","unstructured":"Arun B, Akar U, Gutierrez-Barrera AM, Hortobagyi GN, Ozpolat B. The PARP inhibitor AZD2281 (olaparib) induces autophagy\/mitophagy in BRCA1 and BRCA2 mutant breast cancer cells. Int J Oncol. 2015;47(1):262\u20138. https:\/\/doi.org\/10.3892\/ijo.2015.3003.","journal-title":"Int J Oncol"},{"issue":"1","key":"356_CR15","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13568-019-0836-z","volume":"9","author":"Y Liu","year":"2019","unstructured":"Liu Y, Song H, Song H, Feng X, Zhou C, Huo Z. Targeting autophagy potentiates the anti-tumor effect of PARP inhibitor in pediatric chronic myeloid leukemia. AMB Express. 2019;9(1):108. https:\/\/doi.org\/10.1186\/s13568-019-0836-z.","journal-title":"AMB Express"},{"issue":"4","key":"356_CR16","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1002\/cncr.32600","volume":"126","author":"JM Santiago-O'Farrill","year":"2020","unstructured":"Santiago-O\u2019Farrill JM, Weroha SJ, Hou X, Oberg AL, Heinzen EP, Maurer MJ, et al. Poly(adenosine diphosphate ribose) polymerase inhibitors induce autophagy-mediated drug resistance in ovarian cancer cells, xenografts, and patient-derived xenograft models. Cancer. 2020;126(4):894\u2013907. https:\/\/doi.org\/10.1002\/cncr.32600.","journal-title":"Cancer"},{"issue":"3","key":"356_CR17","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/carcin\/bgz104","volume":"41","author":"W Zai","year":"2020","unstructured":"Zai W, Chen W, Han Y, Wu Z, Fan J, Zhang X, et al. Targeting PARP and autophagy evoked synergistic lethality in hepatocellular carcinoma. Carcinogenesis. 2020;41(3):345\u201357. https:\/\/doi.org\/10.1093\/carcin\/bgz104.","journal-title":"Carcinogenesis"},{"key":"356_CR18","doi-asserted-by":"publisher","unstructured":"Lesage J, DiMauro A, Schab AM, Stidham S, Mullen MM, Fuh KC, et al. DDR2 confers ferroptosis resistance to cancer-associated fibroblasts and attenuates PARPi sensitivity of ovarian tumor cells. Mol Cancer Res. 2025. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-25-0268.","DOI":"10.1158\/1541-7786.Mcr-25-0268"},{"key":"356_CR19","doi-asserted-by":"publisher","first-page":"1598279","DOI":"10.3389\/fphar.2025.1598279","volume":"16","author":"J Zhang","year":"2025","unstructured":"Zhang J, Ouyang D, Liu M, Xiang Y, Li Z. Research progress on ferroptosis and PARP inhibitors in ovarian cancer: action mechanisms and resistance mechanisms. Front Pharmacol. 2025;16:1598279. https:\/\/doi.org\/10.3389\/fphar.2025.1598279.","journal-title":"Front Pharmacol"},{"issue":"1","key":"356_CR20","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3390\/cancers12010164","volume":"12","author":"CM Bebber","year":"2020","unstructured":"Bebber CM, M\u00fcller F, Prieto Clemente L, Weber J, von Karstedt S. Ferroptosis in cancer cell biology. Cancers (Basel). 2020;12(1):164. https:\/\/doi.org\/10.3390\/cancers12010164.","journal-title":"Cancers (Basel)"},{"key":"356_CR21","doi-asserted-by":"publisher","first-page":"1410018","DOI":"10.3389\/fimmu.2024.1410018","volume":"15","author":"K Guo","year":"2024","unstructured":"Guo K, Lu M, Bi J, Yao T, Gao J, Ren F, et al. Ferroptosis: mechanism, immunotherapy and role in ovarian cancer. Front Immunol. 2024;15:1410018. https:\/\/doi.org\/10.3389\/fimmu.2024.1410018.","journal-title":"Front Immunol"},{"key":"356_CR22","doi-asserted-by":"publisher","first-page":"103350","DOI":"10.1016\/j.redox.2024.103350","volume":"76","author":"X Xie","year":"2024","unstructured":"Xie X, Chen C, Wang C, Guo Y, Sun B, Tian J, et al. Targeting GPX4-mediated ferroptosis protection sensitizes BRCA1-deficient cancer cells to PARP inhibitors. Redox Biol. 2024;76:103350. https:\/\/doi.org\/10.1016\/j.redox.2024.103350.","journal-title":"Redox Biol"},{"issue":"2","key":"356_CR23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.molcel.2017.06.017","volume":"69","author":"C Hetz","year":"2018","unstructured":"Hetz C, Papa FR. The unfolded protein response and cell fate control. Mol Cell. 2018;69(2):169\u201381. https:\/\/doi.org\/10.1016\/j.molcel.2017.06.017.","journal-title":"Mol Cell"},{"issue":"4","key":"356_CR24","doi-asserted-by":"publisher","first-page":"411","DOI":"10.2174\/156652409788167096","volume":"9","author":"J Ye","year":"2009","unstructured":"Ye J, Koumenis C. ATF4, an ER stress and hypoxia-inducible transcription factor and its potential role in hypoxia tolerance and tumorigenesis. Curr Mol Med. 2009;9(4):411\u20136. https:\/\/doi.org\/10.2174\/156652409788167096.","journal-title":"Curr Mol Med"},{"key":"356_CR25","doi-asserted-by":"publisher","first-page":"101781","DOI":"10.1016\/j.bbrep.2024.101781","volume":"39","author":"K Deng","year":"2024","unstructured":"Deng K, Li Q, Lu L, Wang L, Cheng Z, Wang S. Proteasome and PARP1 dual-target inhibitor for multiple myeloma: fluzoparib. Biochem Biophys Rep. 2024;39:101781. https:\/\/doi.org\/10.1016\/j.bbrep.2024.101781.","journal-title":"Biochem Biophys Rep"},{"issue":"4","key":"356_CR26","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/pros.23741","volume":"79","author":"D Majera","year":"2019","unstructured":"Majera D, Skrott Z, Bouchal J, Bartkova J, Simkova D, Gachechiladze M, et al. Targeting genotoxic and proteotoxic stress-response pathways in human prostate cancer by clinically available PARP inhibitors, vorinostat and disulfiram. Prostate. 2019;79(4):352\u201362. https:\/\/doi.org\/10.1002\/pros.23741.","journal-title":"Prostate"},{"issue":"3","key":"356_CR27","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1158\/0008-5472.Can-23-1443","volume":"84","author":"H Fan","year":"2024","unstructured":"Fan H, Xu Z, Yao K, Zheng B, Zhang Y, Wang X, et al. Osteoclast cancer cell metabolic cross-talk confers PARP inhibitor resistance in bone metastatic breast cancer. Cancer Res. 2024;84(3):449\u201367. https:\/\/doi.org\/10.1158\/0008-5472.Can-23-1443.","journal-title":"Cancer Res"},{"issue":"6","key":"356_CR28","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/1097-0215(20001215)88:6<928::aid-ijc14>3.0.co;2-p","volume":"88","author":"P Maillet","year":"2000","unstructured":"Maillet P, Chappuis PO, Vaudan G, Dobbie Z, M\u00fcller H, Hutter P, et al. A polymorphism in the ATM gene modulates the penetrance of hereditary non-polyposis colorectal cancer. Int J Cancer. 2000;88(6):928\u201331. https:\/\/doi.org\/10.1002\/1097-0215(20001215)88:6%3c928::aid-ijc14%3e3.0.co;2-p.","journal-title":"Int J Cancer"},{"key":"356_CR29","doi-asserted-by":"publisher","unstructured":"Sriramulu S, Ramachandran M, Subramanian S, Kannan R, Gopinath M, Sollano J, et al. A review on role of ATM gene in hereditary transfer of colorectal cancer. Acta Biomed. 2019;89(4):463\u2013469. https:\/\/doi.org\/10.23750\/abm.v89i4.6095.","DOI":"10.23750\/abm.v89i4.6095"},{"key":"356_CR30","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.freeradbiomed.2021.09.008","volume":"175","author":"C Zhao","year":"2021","unstructured":"Zhao C, Yu D, He Z, Bao L, Feng L, Chen L, et al. Endoplasmic reticulum stress-mediated autophagy activation is involved in cadmium-induced ferroptosis of renal tubular epithelial cells. Free Radic Biol Med. 2021;175:236\u201348. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2021.09.008.","journal-title":"Free Radic Biol Med"},{"key":"356_CR31","doi-asserted-by":"publisher","first-page":"5076271","DOI":"10.1155\/2018\/5076271","volume":"2018","author":"SJ Santini","year":"2018","unstructured":"Santini SJ, Cordone V, Falone S, Mijit M, Tatone C, Amicarelli F, et al. Role of mitochondria in the oxidative stress induced by electromagnetic fields: focus on reproductive systems. Oxid Med Cell Longev. 2018;2018:5076271. https:\/\/doi.org\/10.1155\/2018\/5076271.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"356_CR32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrm3028","volume":"12","author":"RJ Youle","year":"2011","unstructured":"Youle RJ, Narendra DP. Mechanisms of mitophagy. Nat Rev Mol Cell Biol. 2011;12(1):9\u201314. https:\/\/doi.org\/10.1038\/nrm3028.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"12","key":"356_CR33","doi-asserted-by":"publisher","first-page":"6611","DOI":"10.1093\/nar\/gkaa393","volume":"48","author":"X Dan","year":"2020","unstructured":"Dan X, Babbar M, Moore A, Wechter N, Tian J, Mohanty JG, et al. DNA damage invokes mitophagy through a pathway involving Spata18. Nucleic Acids Res. 2020;48(12):6611\u201323. https:\/\/doi.org\/10.1093\/nar\/gkaa393.","journal-title":"Nucleic Acids Res"},{"key":"356_CR34","doi-asserted-by":"publisher","unstructured":"Gallyas F, Jr., Sumegi B. Mitochondrial Protection by PARP Inhibition. Int J Mol Sci. 2020;21(8). https:\/\/doi.org\/10.3390\/ijms21082767.","DOI":"10.3390\/ijms21082767"},{"issue":"2","key":"356_CR35","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.bbrc.2020.03.079","volume":"526","author":"L Chen","year":"2020","unstructured":"Chen L, Qiao L, Bian Y, Sun X. GDF15 knockdown promotes erastin-induced ferroptosis by decreasing SLC7A11 expression. Biochem Biophys Res Commun. 2020;526(2):293\u20139. https:\/\/doi.org\/10.1016\/j.bbrc.2020.03.079.","journal-title":"Biochem Biophys Res Commun"},{"key":"356_CR36","doi-asserted-by":"publisher","first-page":"905115","DOI":"10.3389\/fnagi.2022.905115","volume":"14","author":"M Xia","year":"2022","unstructured":"Xia M, Zhang Q, Zhang Y, Li R, Zhao T, Chen L, et al. Growth differentiation factor 15 regulates oxidative stress-dependent ferroptosis post spinal cord injury by stabilizing the p62-Keap1-Nrf2 signaling pathway. Front Aging Neurosci. 2022;14:905115. https:\/\/doi.org\/10.3389\/fnagi.2022.905115.","journal-title":"Front Aging Neurosci"},{"key":"356_CR37","doi-asserted-by":"publisher","first-page":"1117297","DOI":"10.3389\/fimmu.2023.1117297","volume":"14","author":"RY Chen","year":"2023","unstructured":"Chen RY, Li DW, Xie H, Liu XW, Zhuang SY, Wu HY, et al. Gene signature and prediction model of the mitophagy-associated immune microenvironment in renal ischemia-reperfusion injury. Front Immunol. 2023;14:1117297. https:\/\/doi.org\/10.3389\/fimmu.2023.1117297.","journal-title":"Front Immunol"},{"key":"356_CR38","doi-asserted-by":"publisher","first-page":"119356","DOI":"10.1016\/j.lfs.2021.119356","volume":"275","author":"A Li","year":"2021","unstructured":"Li A, Zhao F, Zhao Y, Liu H, Wang Z. ATF4-mediated GDF15 suppresses LPS-induced inflammation and MUC5AC in human nasal epithelial cells through the PI3K\/Akt pathway. Life Sci. 2021;275:119356. https:\/\/doi.org\/10.1016\/j.lfs.2021.119356.","journal-title":"Life Sci"},{"key":"356_CR39","doi-asserted-by":"publisher","unstructured":"Soni A, Lin X, Mladenov E, Mladenova V, Stuschke M, Iliakis G. BMN673 Is a PARP Inhibitor with Unique Radiosensitizing Properties: Mechanisms and Potential in Radiation Therapy. Cancers (Basel). 2022;14(22). https:\/\/doi.org\/10.3390\/cancers14225619.","DOI":"10.3390\/cancers14225619"},{"issue":"11","key":"356_CR40","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1007\/s00432-017-2487-2","volume":"143","author":"Y Xin","year":"2017","unstructured":"Xin Y, Jiang F, Yang C, Yan Q, Guo W, Huang Q, et al. Role of autophagy in regulating the radiosensitivity of tumor cells. J Cancer Res Clin Oncol. 2017;143(11):2147\u201357. https:\/\/doi.org\/10.1007\/s00432-017-2487-2.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"8","key":"356_CR41","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1158\/1078-0432.Ccr-09-2758","volume":"16","author":"A Mukhopadhyay","year":"2010","unstructured":"Mukhopadhyay A, Elattar A, Cerbinskaite A, Wilkinson SJ, Drew Y, Kyle S, et al. Development of a functional assay for homologous recombination status in primary cultures of epithelial ovarian tumor and correlation with sensitivity to poly(ADP-ribose) polymerase inhibitors. Clin Cancer Res. 2010;16(8):2344\u201351. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-09-2758.","journal-title":"Clin Cancer Res"},{"issue":"22","key":"356_CR42","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1200\/jco.2009.27.5719","volume":"28","author":"PA Konstantinopoulos","year":"2010","unstructured":"Konstantinopoulos PA, Spentzos D, Karlan BY, Taniguchi T, Fountzilas E, Francoeur N, et al. Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer. J Clin Oncol. 2010;28(22):3555\u201361. https:\/\/doi.org\/10.1200\/jco.2009.27.5719.","journal-title":"J Clin Oncol"},{"issue":"12","key":"356_CR43","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.2217\/fon-2016-0002","volume":"12","author":"ZB Jenner","year":"2016","unstructured":"Jenner ZB, Sood AK, Coleman RL. Evaluation of rucaparib and companion diagnostics in the PARP inhibitor landscape for recurrent ovarian cancer therapy. Future Oncol. 2016;12(12):1439\u201356. https:\/\/doi.org\/10.2217\/fon-2016-0002.","journal-title":"Future Oncol"},{"issue":"11","key":"356_CR44","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1093\/jnci\/djy148","volume":"110","author":"M Oh","year":"2018","unstructured":"Oh M, McBride A, Yun S, Bhattacharjee S, Slack M, Martin JR, et al. BRCA1 and BRCA2 gene mutations and colorectal cancer risk: systematic review and meta-analysis. J Natl Cancer Inst. 2018;110(11):1178\u201389. https:\/\/doi.org\/10.1093\/jnci\/djy148.","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"356_CR45","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.annonc.2020.05.027","volume":"31","author":"G Mauri","year":"2020","unstructured":"Mauri G, Arena S, Siena S, Bardelli A, Sartore-Bianchi A. The DNA damage response pathway as a land of therapeutic opportunities for colorectal cancer. Ann Oncol. 2020;31(9):1135\u201347. https:\/\/doi.org\/10.1016\/j.annonc.2020.05.027.","journal-title":"Ann Oncol"},{"issue":"1","key":"356_CR46","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.celrep.2018.03.076","volume":"23","author":"TA Knijnenburg","year":"2018","unstructured":"Knijnenburg TA, Wang L, Zimmermann MT, Chambwe N, Gao GF, Cherniack AD, et al. Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas. Cell Rep. 2018;23(1):239-254.e236. https:\/\/doi.org\/10.1016\/j.celrep.2018.03.076.","journal-title":"Cell Rep"},{"key":"356_CR47","doi-asserted-by":"publisher","unstructured":"Heeke AL, Pishvaian MJ, Lynce F, Xiu J, Brody JR, Chen WJ, et al. Prevalence of Homologous Recombination-Related Gene Mutations Across Multiple Cancer Types. JCO Precis Oncol. 2018;2018. https:\/\/doi.org\/10.1200\/po.17.00286.","DOI":"10.1200\/po.17.00286"},{"issue":"2","key":"356_CR48","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/jnci\/djab169","volume":"114","author":"R Moretto","year":"2022","unstructured":"Moretto R, Elliott A, Zhang J, Arai H, Germani MM, Conca V, et al. Homologous recombination deficiency alterations in colorectal cancer: clinical, molecular, and prognostic implications. J Natl Cancer Inst. 2022;114(2):271\u20139. https:\/\/doi.org\/10.1093\/jnci\/djab169.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"356_CR49","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ccr.2011.01.047","volume":"19","author":"LW Ellisen","year":"2011","unstructured":"Ellisen LW. PARP inhibitors in cancer therapy: promise, progress, and puzzles. Cancer Cell. 2011;19(2):165\u20137. https:\/\/doi.org\/10.1016\/j.ccr.2011.01.047.","journal-title":"Cancer Cell"},{"issue":"5","key":"356_CR50","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/ppo.0000000000000219","volume":"22","author":"E Castro","year":"2016","unstructured":"Castro E, Mateo J, Olmos D, de Bono JS. Targeting DNA repair: the role of PARP inhibition in the treatment of castration-resistant prostate cancer. Cancer J. 2016;22(5):353\u20136. https:\/\/doi.org\/10.1097\/ppo.0000000000000219.","journal-title":"Cancer J"},{"key":"356_CR51","doi-asserted-by":"publisher","first-page":"110475","DOI":"10.1016\/j.radonc.2024.110475","volume":"200","author":"X Lin","year":"2024","unstructured":"Lin X, Soni A, Hessenow R, Sun Y, Mladenov E, Guberina M, et al. Talazoparib enhances resection at DSBs and renders HR-proficient cancer cells susceptible to Pol\u03b8 inhibition. Radiother Oncol. 2024;200:110475. https:\/\/doi.org\/10.1016\/j.radonc.2024.110475.","journal-title":"Radiother Oncol"},{"issue":"7","key":"356_CR52","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/s41416-020-01238-0","volume":"124","author":"G Pai Bellare","year":"2021","unstructured":"Pai Bellare G, Saha B, Patro BS. Targeting autophagy reverses de novo resistance in homologous recombination repair proficient breast cancers to PARP inhibition. Br J Cancer. 2021;124(7):1260\u201374. https:\/\/doi.org\/10.1038\/s41416-020-01238-0.","journal-title":"Br J Cancer"},{"issue":"9","key":"356_CR53","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1158\/1541-7786.Mcr-23-0680","volume":"22","author":"JM Santiago-O'Farrill","year":"2024","unstructured":"Santiago-O\u2019Farrill JM, Blessing Bollu A, Yang H, Orellana V, Pina M, Zhang X, et al. Crizotinib Enhances PARP Inhibitor Efficacy in Ovarian Cancer Cells and Xenograft Models by Inducing Autophagy. Mol Cancer Res. 2024;22(9):840\u201351. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-23-0680.","journal-title":"Mol Cancer Res"},{"issue":"1","key":"356_CR54","doi-asserted-by":"publisher","first-page":"20924","DOI":"10.1038\/s41598-020-77908-z","volume":"10","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Lian X, Xie W, Quan J, Liao M, Wu Y, et al. Role of PARP1-mediated autophagy in EGFR-TKI resistance in non-small cell lung cancer. Sci Rep. 2020;10(1):20924. https:\/\/doi.org\/10.1038\/s41598-020-77908-z.","journal-title":"Sci Rep"},{"issue":"1","key":"356_CR55","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3109\/00016489.2013.844365","volume":"134","author":"Y Wang","year":"2014","unstructured":"Wang Y, Yin W, Zhu X. Blocked autophagy enhances radiosensitivity of nasopharyngeal carcinoma cell line CNE-2 in vitro. Acta Otolaryngol. 2014;134(1):105\u201310. https:\/\/doi.org\/10.3109\/00016489.2013.844365.","journal-title":"Acta Otolaryngol"},{"issue":"10","key":"356_CR56","doi-asserted-by":"publisher","first-page":"e1437","DOI":"10.1038\/cddis.2014.415","volume":"5","author":"L Chang","year":"2014","unstructured":"Chang L, Graham PH, Hao J, Ni J, Bucci J, Cozzi PJ, et al. PI3K\/Akt\/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathways. Cell Death Dis. 2014;5(10):e1437. https:\/\/doi.org\/10.1038\/cddis.2014.415.","journal-title":"Cell Death Dis"},{"key":"356_CR57","doi-asserted-by":"publisher","first-page":"749987","DOI":"10.3389\/fonc.2021.749987","volume":"11","author":"Q Li","year":"2021","unstructured":"Li Q, Xia L, Sun C, Zhang H, Zheng M, Zhang H, et al. Role of borneol induced autophagy in enhancing radiosensitivity of malignant glioma. Front Oncol. 2021;11:749987. https:\/\/doi.org\/10.3389\/fonc.2021.749987.","journal-title":"Front Oncol"},{"issue":"2","key":"356_CR58","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1089\/dna.2020.5730","volume":"40","author":"L Sun","year":"2021","unstructured":"Sun L, Dong H, Zhang W, Wang N, Ni N, Bai X, et al. Lipid peroxidation, GSH depletion, and SLC7A11 inhibition are common causes of EMT and ferroptosis in A549 cells, but different in specific mechanisms. DNA Cell Biol. 2021;40(2):172\u201383. https:\/\/doi.org\/10.1089\/dna.2020.5730.","journal-title":"DNA Cell Biol"},{"key":"356_CR59","doi-asserted-by":"publisher","first-page":"215919","DOI":"10.1016\/j.canlet.2022.215919","volume":"550","author":"D Shen","year":"2022","unstructured":"Shen D, Luo J, Chen L, Ma W, Mao X, Zhang Y, et al. Parpi treatment enhances radiotherapy-induced ferroptosis and antitumor immune responses via the cGAS signaling pathway in colorectal cancer. Cancer Lett. 2022;550:215919. https:\/\/doi.org\/10.1016\/j.canlet.2022.215919.","journal-title":"Cancer Lett"},{"issue":"1","key":"356_CR60","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/s41467-025-56344-5","volume":"16","author":"B Huang","year":"2025","unstructured":"Huang B, Wang H, Liu S, Hao M, Luo D, Zhou Y, et al. Palmitoylation-dependent regulation of GPX4 suppresses ferroptosis. Nat Commun. 2025;16(1):867. https:\/\/doi.org\/10.1038\/s41467-025-56344-5.","journal-title":"Nat Commun"},{"issue":"9","key":"356_CR61","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.3724\/abbs.2022109","volume":"54","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Hu Q, Ye S, Xiang L. Inhibition of the PIN1-NRF2\/GPX4 axis imparts sensitivity to cisplatin in cervical cancer cells. Acta Biochim Biophys Sin (Shanghai). 2022;54(9):1325\u201335. https:\/\/doi.org\/10.3724\/abbs.2022109.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"6","key":"356_CR62","doi-asserted-by":"publisher","first-page":"114","DOI":"10.15698\/cst2020.06.221","volume":"4","author":"D Grasso","year":"2020","unstructured":"Grasso D, Zampieri LX, Capel\u00f4a T, Van de Velde JA, Sonveaux P. Mitochondria in cancer. Cell Stress. 2020;4(6):114\u201346. https:\/\/doi.org\/10.15698\/cst2020.06.221.","journal-title":"Cell Stress"},{"issue":"2","key":"356_CR63","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/mco2.16","volume":"1","author":"Y Liu","year":"2020","unstructured":"Liu Y, Shi Y. Mitochondria as a target in cancer treatment. MedComm. 2020;1(2):129\u201339. https:\/\/doi.org\/10.1002\/mco2.16.","journal-title":"MedComm"},{"issue":"8","key":"356_CR64","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41419-023-06045-y","volume":"14","author":"Y Liu","year":"2023","unstructured":"Liu Y, Lu S, Wu LL, Yang L, Yang L, Wang J. The diversified role of mitochondria in ferroptosis in cancer. Cell Death Dis. 2023;14(8):519. https:\/\/doi.org\/10.1038\/s41419-023-06045-y.","journal-title":"Cell Death Dis"},{"key":"356_CR65","doi-asserted-by":"publisher","first-page":"111207","DOI":"10.1016\/j.mad.2020.111207","volume":"186","author":"M Babbar","year":"2020","unstructured":"Babbar M, Basu S, Yang B, Croteau DL, Bohr VA. Mitophagy and DNA damage signaling in human aging. Mech Ageing Dev. 2020;186:111207. https:\/\/doi.org\/10.1016\/j.mad.2020.111207.","journal-title":"Mech Ageing Dev"},{"key":"356_CR66","doi-asserted-by":"publisher","unstructured":"Sugimura-Nagata A, Koshino A, Nagao K, Nagano A, Komura M, Ueki A, et al. SPATA18 Expression Predicts Favorable Clinical Outcome in Colorectal Cancer. Int J Mol Sci. 2022;23(5). https:\/\/doi.org\/10.3390\/ijms23052753.","DOI":"10.3390\/ijms23052753"},{"issue":"14","key":"356_CR67","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1007\/s00018-012-1173-4","volume":"70","author":"S Deegan","year":"2013","unstructured":"Deegan S, Saveljeva S, Gorman AM, Samali A. Stress-induced self-cannibalism: on the regulation of autophagy by endoplasmic reticulum stress. Cell Mol Life Sci. 2013;70(14):2425\u201341. https:\/\/doi.org\/10.1007\/s00018-012-1173-4.","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"356_CR68","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/s1097-2765(00)80330-5","volume":"5","author":"HP Harding","year":"2000","unstructured":"Harding HP, Zhang Y, Bertolotti A, Zeng H, Ron D. Perk is essential for translational regulation and cell survival during the unfolded protein response. Mol Cell. 2000;5(5):897\u2013904. https:\/\/doi.org\/10.1016\/s1097-2765(00)80330-5.","journal-title":"Mol Cell"},{"issue":"3","key":"356_CR69","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/s1097-2765(03)00105-9","volume":"11","author":"HP Harding","year":"2003","unstructured":"Harding HP, Zhang Y, Zeng H, Novoa I, Lu PD, Calfon M, et al. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol Cell. 2003;11(3):619\u201333. https:\/\/doi.org\/10.1016\/s1097-2765(03)00105-9.","journal-title":"Mol Cell"},{"key":"356_CR70","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.freeradbiomed.2017.04.018","volume":"108","author":"E Hocsak","year":"2017","unstructured":"Hocsak E, Szabo V, Kalman N, Antus C, Cseh A, Sumegi K, et al. PARP inhibition protects mitochondria and reduces ROS production via PARP-1-ATF4-MKP-1-MAPK retrograde pathway. Free Radic Biol Med. 2017;108:770\u201384. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.04.018.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"356_CR71","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s13287-023-03371-y","volume":"14","author":"W Li","year":"2023","unstructured":"Li W, Li W, Zhang W, Wang H, Yu L, Yang P, et al. Exogenous melatonin ameliorates steroid-induced osteonecrosis of the femoral head by modulating ferroptosis through GDF15-mediated signaling. Stem Cell Res Ther. 2023;14(1):171. https:\/\/doi.org\/10.1186\/s13287-023-03371-y.","journal-title":"Stem Cell Res Ther"},{"issue":"8","key":"356_CR72","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1038\/s12276-023-01046-5","volume":"55","author":"TT Nguyen","year":"2023","unstructured":"Nguyen TT, Wei S, Nguyen TH, Jo Y, Zhang Y, Park W, et al. Mitochondria-associated programmed cell death as a therapeutic target for age-related disease. Exp Mol Med. 2023;55(8):1595\u2013619. https:\/\/doi.org\/10.1038\/s12276-023-01046-5.","journal-title":"Exp Mol Med"},{"key":"356_CR73","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.atherosclerosis.2018.12.009","volume":"281","author":"K Ackermann","year":"2019","unstructured":"Ackermann K, Bonaterra GA, Kinscherf R, Schwarz A. Growth differentiation factor-15 regulates oxLDL-induced lipid homeostasis and autophagy in human macrophages. Atherosclerosis. 2019;281:128\u201336. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.12.009.","journal-title":"Atherosclerosis"},{"issue":"5","key":"356_CR74","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1053\/j.gastro.2020.12.015","volume":"160","author":"Y Myojin","year":"2021","unstructured":"Myojin Y, Hikita H, Sugiyama M, Sasaki Y, Fukumoto K, Sakane S, et al. Hepatic Stellate Cells in Hepatocellular Carcinoma Promote Tumor Growth Via Growth Differentiation Factor 15 Production. Gastroenterology. 2021;160(5):1741-1754.e1716. https:\/\/doi.org\/10.1053\/j.gastro.2020.12.015.","journal-title":"Gastroenterology"},{"key":"356_CR75","doi-asserted-by":"publisher","first-page":"711776","DOI":"10.3389\/fonc.2021.711776","volume":"11","author":"Y Shao","year":"2021","unstructured":"Shao Y, Jia H, Huang L, Li S, Wang C, Aikemu B, et al. An original ferroptosis-related gene signature effectively predicts the prognosis and clinical status for colorectal cancer patients. Front Oncol. 2021;11:711776. https:\/\/doi.org\/10.3389\/fonc.2021.711776.","journal-title":"Front Oncol"},{"issue":"10","key":"356_CR76","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1016\/j.apsb.2021.01.003","volume":"11","author":"M Jiang","year":"2021","unstructured":"Jiang M, Jia K, Wang L, Li W, Chen B, Liu Y, et al. Alterations of DNA damage response pathway: biomarker and therapeutic strategy for cancer immunotherapy. Acta Pharm Sin B. 2021;11(10):2983\u201394. https:\/\/doi.org\/10.1016\/j.apsb.2021.01.003.","journal-title":"Acta Pharm Sin B"},{"issue":"7","key":"356_CR77","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/em.22397","volume":"61","author":"MK Mustofa","year":"2020","unstructured":"Mustofa MK, Tanoue Y, Tateishi C, Vaziri C, Tateishi S. Roles of Chk2\/CHEK2 in guarding against environmentally induced DNA damage and replication-stress. Environ Mol Mutagen. 2020;61(7):730\u20135. https:\/\/doi.org\/10.1002\/em.22397.","journal-title":"Environ Mol Mutagen"},{"issue":"1","key":"356_CR78","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13045-022-01360-x","volume":"15","author":"S Li","year":"2022","unstructured":"Li S, Wang L, Wang Y, Zhang C, Hong Z, Han Z. The synthetic lethality of targeting cell cycle checkpoints and PARPs in cancer treatment. J Hematol Oncol. 2022;15(1):147. https:\/\/doi.org\/10.1186\/s13045-022-01360-x.","journal-title":"J Hematol Oncol"},{"key":"356_CR79","doi-asserted-by":"publisher","unstructured":"Huff LA, Yan S, Clemens MG. Mechanisms of Ataxia Telangiectasia Mutated (ATM) Control in the DNA Damage Response to Oxidative Stress, Epigenetic Regulation, and Persistent Innate Immune Suppression Following Sepsis. Antioxidants (Basel). 2021;10(7). https:\/\/doi.org\/10.3390\/antiox10071146.","DOI":"10.3390\/antiox10071146"},{"issue":"11","key":"356_CR80","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.tcb.2020.09.002","volume":"30","author":"M Gonz\u00e1lez-Quiroz","year":"2020","unstructured":"Gonz\u00e1lez-Quiroz M, Blondel A, Sagredo A, Hetz C, Chevet E, Pedeux R. When endoplasmic reticulum proteostasis meets the DNA damage response. Trends Cell Biol. 2020;30(11):881\u201391. https:\/\/doi.org\/10.1016\/j.tcb.2020.09.002.","journal-title":"Trends Cell Biol"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-025-00356-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-025-00356-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-025-00356-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T02:59:06Z","timestamp":1763693946000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-025-00356-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["356"],"URL":"https:\/\/doi.org\/10.1186\/s43556-025-00356-6","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experiments do not involve human subjects. The animal experiments were performed at the core facility of Chongqing Medical University, Chongqing, China, which holds ethical permits from the Laboratory Animal Management and Use Committee of Chongqing Medical University (IACUC-CQMU-2023\u201312089).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read the final version of the manuscript and agree with its publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"113"}}